Clinical Trial

Intraoperative Autonomic Blockade for Laparoscopic Cholecystectomy

Study acronym: ANB
Recruiting Phase 4
View on ClinicalTrials.gov →
Record status
This record was last updated January 28, 2025 (before its estimated November 1, 2025 completion). Its status may not reflect the trial's current state.
Summary
This study proposes infiltrating the hepatoduodenal ligament and the serosal reflection of the gallbladder cystic plate with a combination of Bupivacaine (a long-acting local anesthetic) and Dexamethasone (a corticosteroid). This technique aims to block the hepatic branches of the celiac plexus to improve visceral pain control and its associated clinical manifestations, reduce analgesic requirements, and lower readmission rates, thereby facilitating recovery.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-12-21.
Status change: Not Yet Recruiting → Recruiting 2025-01-25
Trial Details
NCT Number NCT06753500
Lead Sponsor Universidad Simón Bolívar
Conditions Visceral Pain, Analgesia, Opioid Use, Postoperative Nausea, Postoperative Vomiting
Enrollment 60 participants
Start Date 2025-01-15
Primary Completion 2025-11-01 (estimated)
Study Completion 2025-11-04 (estimated)
Updated on ClinicalTrials.gov 2025-01-28